Pub. Date : 2021 Jan
PMID : 33569315
4 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Phase 1/2 study of alectinib in RET-rearranged previously-treated non-small cell lung cancer (ALL-RET). | alectinib | ret proto-oncogene | Homo sapiens |
| 2 | Phase 1/2 study of alectinib in RET-rearranged previously-treated non-small cell lung cancer (ALL-RET). | alectinib | ret proto-oncogene | Homo sapiens |
| 3 | The primary endpoint was the objective response rate (ORR) in RET inhibitor-naive patients treated with the RD of alectinib. | alectinib | ret proto-oncogene | Homo sapiens |
| 4 | Conclusions: Alectinib exerts limited activity against RET-rearranged NSCLC. | alectinib | ret proto-oncogene | Homo sapiens |